Primary Manuscripts
Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe
Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav 2021 Jun;25(6):1890-1900.
Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial
Naidoo K, Mansoor LE, Katz AW, Garcia M, Kemigisha D, Morar NS, Zimba CC, Chitukuta M, Reddy K, Soto-Torres L, Naidoo S, Montgomery ET. Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial. J Acquir Immune Defic Syndr 2021 Apr 1;86(4):e90-e96. PMCID: PMC7902420
Reasons for non-adherence to the dapivirine vaginal ring: Narrative explanations of objective drug-level results
Montgomery ET, Stadler J, Naidoo S, Katz AW, Laborde N, Garcia M, Reddy K, Mansoor LE, Etima J, Zimba C, Chitukuta M, Soto-Torres L. Reasons for non-adherence to the dapivirine vaginal ring: Narrative explanations of objective drug-level results. AIDS 2018 July 17; 32(11):1517-1525. PMCID: 29957723
Other Key Manuscripts
Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention.
Katz AWK, Mansoor LE, Tsidya M, Mathebula F, Singh D, Siva S, Akello C, Chitowa TH, Garcia M, Soto-Torres L, Montgomery ET. Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 2021 Jun 28. Epub ahead of print
The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention
Katz AWK, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, Zimba C, Montgomery ET. The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 2020;24(8):2387-2399.